株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

臨床ラボサービス市場

Clinical Laboratory Services Market

発行 Kalorama Information 商品コード 341698
出版日 ページ情報 英文 185 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.48円で換算しております。
Back to Top
臨床ラボサービス市場 Clinical Laboratory Services Market
出版日: 2017年03月10日 ページ情報: 英文 185 Pages
概要

ラボサービスは医療システムにおける重要な構成部門であり 体外診断検査の商業化においても重要な役割を担っています。医師による診断の約80%は臨床テストの結果に基づいたものであり、これらのテストのかなりの数が臨床ラボサービスプロバイダーによって行われています。

当レポートでは、各種臨床ラボサービスの市場を米国を中心に調査し、臨床ラボの概要、各種検査の種類と概要、ラボの分類とラボ区分別の主な動向、産業への影響因子 (高齢化・法規制・償還・保険の影響など)の分析、主要参入企業のプロファイル、米国および世界の主要地域の市場成長予測などをまとめています。

エグゼクティブサマリー

産業概要

  • 臨床ラボの概要
  • テストとサービス
  • ルーチン検査
    • 血球計算
    • コレステロール値検査
    • HIV検査
    • PAP検査
    • 妊娠検査
    • 薬物乱用検査
    • 尿検査
  • 専門的検査
    • 内分泌系検査
    • 特殊検査
    • 遺伝子検査
    • 免疫学的・分子細菌学的検査
    • 癌検査
    • 血清学的検査
  • 米国の臨床ラボ産業の構造
  • CLIA登録ラボ:タイプ別
  • 独立系臨床ラボ
    • 米国での成長動向
  • 病院ベースのラボ
    • 米国の病院データ
    • 米国の病院滞在日数統計
    • 米国での成長動向
  • 診療所ラボ
    • 米国の医師数
    • 米国での成長動向
  • 介護施設・在宅医療
    • 米国の介護施設数
    • 米国の在宅医療関連施設
    • 米国での成長動向
  • 薬局ベースのラボ
    • 米国での成長動向
  • 人工透析クリニック
    • 米国での成長動向
  • 世界の臨床ラボの構造
  • 世界の病院・救急病院のデータ

臨床ラボ産業の課題と各種動向

  • 課題と各種動向:概要
  • 人口動態
    • 世界の人口動態
    • 地域別人口:概要
  • 高齢者人口
    • 慢性疾患・症状の発症率
    • 外科手術件数
  • 法規制の概要
  • 医療費支払い者と償還
    • ラボサービスの支払い者の各種タイプ
    • 医療費償還の動向
    • 医療改革
  • ESRD (腎臓疾患) 患者への保険支払い
    • ESRDクオリティインセンティブプログラム
  • HIPPA
  • 民間保険事業者
  • 情報技術の新たな発展

主要参入企業

  • サマリー
  • Bio-Reference Laboratories
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Clarient, Inc. (A GE Healthcare Company)
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 所在地
  • DaVita Healthcare Partners, Inc.
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Genomic Health, Inc.
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Genoptix, Inc.
    • 企業概要
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Laboratory Corporation of America
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Myriad Genetics, Inc
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Quest Diagnostics, Inc.
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Spectra Laboratories: A Fresenius Company
    • 企業概要
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地
  • Sonic Healthcare Limited
    • 企業概要
    • 業績レビュー
    • 主な買収・提携・協力関係
    • 製品・サービス
    • 成長戦略
    • 所在地

市場動向・サマリー

  • 世界市場の概要
  • サービス市場:テスト区分別
    • ルーチン検査
    • 専門的検査
  • 米国市場の概要
  • 市場分析:ラボタイプ別
    • 病院ベースの臨床ラボ
    • 独立系ラボ
    • 診療所ラボ
  • 市場分析:テストタイプ別
    • ルーチン検査
    • 専門的検査
  • 米国の競合分析
  • 国際市場の概要
  • 国際市場とその動向
    • アジア太平洋
    • 欧州・中東
    • ラテンアメリカ

主要企業のリスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI15279153

Clinical laboratories are an essential part of the health industry. It is estimated that approximately 80% of physicians' diagnoses are a result of laboratory tests. In addition to diagnosing patients, reasons clinical lab testing may be performed include evaluating disease progression, monitoring drug treatment and conditions, and determining individual therapy, among others. Clinical Laboratory Services Market provides an overview of the clinical laboratory industry and the trends driving growth. Market data presented include the following:

  • Global Clinical Laboratory Market Analysis, 2010-2021
  • Leading Market Participants, Global Service Revenues, 2014, 2015 and 2016
  • Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
  • Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers, 2010 vs. 2016
  • Global Clinical Laboratory Revenue Share by General Test Segment, 2016 (%)
  • Global Clinical Laboratory Market Analysis by Test Segment (Routine vs. Specialty), 2010-2021
  • Global Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2010-2021
  • Global Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2010-2021

Internationally, the clinical laboratory market is growing. Clinical Laboratory Services Market presents information as a global focused market report. Key regions discussed include Northern America; Europe, Middle East, and Africa (EMEA); Asia Pacific; and Latin America. Datasets provided include the following:

  • Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
  • Northern America Market Value by Country, 2016 (Canada, United States, Rest of Northern America)
  • U.S. Clinical Laboratory Market Analysis, 2010-2021
  • U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (Hospital-based, Physician-office, Independent, Total)
  • Clinical Laboratory Market Share by Laboratory Type, 2021 (Independent, Hospital-based, Physician-office)
  • U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2016 (Routine Clinical Chemistry, Toxicology / Drug abuse, Tissue Pathology, Other Specialty)
  • Europe/Middle East and Africa Market Value by Country, 2016 (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
  • Asia Pacific Market Value by Country, 2016 (China, Japan, India, South Korea, Australia, Rest of Asia Pacific, Total)
  • Latin America Market Value by Country, 2016 (Brazil, Mexico, Rest of Latin America, Total)

There are several primary issues and trends affecting the clinical laboratory market. Demographics, disease prevalence, and increasing life expectancy will continue to fuel growth in the future. New developments will also positively influence growth. Some of these issues are discussed in this study.

Issues and trends explored in this study include demographics, growing incidence of disease, new developments, regulatory environment, laboratory regulation, reimbursement, payer types, and developments in personalized medicine.

The clinical laboratory market is highly competitive in terms of prices, locations, and services offered. Larger laboratories have advantages in the market due to the wide exposure, large number of locations, and greater financial positions. The report profiles companies that are the leaders in the industry, including:

  • Alere, Inc.
  • Bio-Reference Laboratories - OPKO
  • DaVita Healthcare Partners, Inc.
  • Genomic Health, Inc.
  • Laboratory Corporation of America
  • Myriad Genetics, Inc.
  • Neogenomics, Inc.
  • Quest Diagnostics, Inc.
  • Siemens Healthineers
  • Sonic Healthcare Limited
  • Spectra Laboratories: A Fresenius Company
  • Synlab International GMBH

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, healthcare providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

INDUSTRY AT A GLANCE

SCOPE AND METHODOLOGY

GLOBAL MARKET OVERVIEW

  • Table 1-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer's level)
  • Figure 1-1: Global Clinical Laboratory Market Analysis: 2010-2021

MARKET CONCLUSIONS

KEY ISSUES AND TRENDS AFFECTING THE MARKET

LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

CLINICAL LABORATORY DESCRIPTION

TESTING AND SERVICES

  • Routine Testing
  • Table 2-1: Laboratory Reference Parameters for Complete Blood Count (CBC)
  • Table 2-2: High Cholesterol Risk Categories (Desirable levels, Borderline high, High risk)
  • Table 2-3: Raised or At-Risk Total Cholesterol (> = 190 mg/dL), Age Standardized Estimates, 2008 data (Iceland, Germany, Denmark, United Kingdom, Ireland, Italy, France, Netherlands, Switzerland, United Arab Emirates, Singapore, Japan, Poland, Thailand, Australia, United States, Israel, Canada, Mexico, Russian Federation, Argentina, Brazil, Philippines, Republic of Korea, Turkey, Saudi Arabia, Venezuela, China, India)
  • Table 2-4: Number of Reported HIV Testing and Counseling Services by Country, 2014 (India, Ethiopia, Uganda, Kenya, Nigeria, Mozambique, South Africa, Rwanda, United Republic of Tanzania, Zambia, Mexico, Kazakhstan, Malawi, Viet Nam, Côte d'Ivoire, Democratic Republic of the Congo, Zimbabwe, Malaysia, Thailand, Haiti, Peru, Belarus, Indonesia, Burundi, Cuba)
  • Table 2-5: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2015 (Afghanistan, Argentina, Australia, Belgium, Brazil, Canada, China, Democratic People's Republic of Korea, Denmark, France, Germany, India, Indonesia, Iran [Islamic Republic of], Iraq, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Philippines, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Venezuela [Bolivarian Republic of], Viet Nam)
  • Table 2-6: HCG Levels in Pregnant Women by Days Past Ovulation
  • Table 2-7: Substance Detection Periods by Test Method (Alcohol, Cocaine, Morphine, Phenobarbital, Methadone, PCP, LSD, Heroin, Methamphetamine; Urine, Blood, Hair)
  • Table 2-8: Screening and Brief Interventions for Substance Abuse by Select Country, 2008 Data (Afghanistan, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Iran [Islamic Republic of], Iraq, Ireland, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Pakistan, Philippines, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Venezuela [Bolivarian Republic of])
  • Table 2-9: Normal Reference Levels in a Medical Urinalysis
  • Specialty Testing

GLOBAL CLINICAL LABORATORY STRUCTURE

  • Global Hospital/Acute Care Data
  • Table 2-10: Hospital Density per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany, Iceland, Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
  • Figure 2-1: Hospitals per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany, Iceland, Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
  • Global Access to Physicians
  • Table 2-11: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States, Vietnam)
  • Figure 2-2: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States, Vietnam)
  • Global Nursing Establishments and Assisted Living Facilities
  • Table 2-12: Estimated Nursing Service Establishments and Care Centers by Country (Canada, China, France, Germany, Japan, United Kingdom, United States)
  • Figure 2-3: Estimated Nursing Service Establishments and Care Centers by Country (Canada, China, France, Germany, Japan, United Kingdom, United States)
  • Global Dialysis Clinics
  • Figure 2-4: Worldwide Dialysis Centers (Number of Facilities), 2001-2014
  • U.S. CLINICAL LABORATORY INDUSTRY STRUCTURE
  • Figure 2-5: Growth in Clinical Laboratories, 1997-2016

CLIA Laboratory Registration, Laboratories by Type

  • Figure 2-6: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: 1/2017 (Physician Office, Skilled Nursing / Nursing Facility, Home Health Agency, Hospital, Pharmacy, Community Clinic, ESRD Clinic, Independent, Others)
  • Table 2-13: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined), January 2017 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank, Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care Facility for Mentally Retarded, Mobile Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing/Nursing Facility, Tissue Bank/Repository, Other, Total)
  • Figure 2-7: Change in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2013, July 2015 and January 2017 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Banks, Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care - Mentally Retarded, Mobile Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing, Tissue Bank/Repositories, Other)
  • Independent Clinical Laboratories
  • Table 2-14: Leading U.S. Independent Laboratory Groups, as of January 2017
  • Figure 2-8: Leading U.S. Independent Laboratory Groups, Distribution of Centers, as of January 2017
  • Figure 2-9: Growth in U.S. Independent Laboratory Facilities, mid-2011 through January 2017
  • Hospital-based Laboratories
  • Table 2-15: U.S. Hospital Types
  • Table 2-16: U.S. Registered Hospitals by Type, 2010 through 2015 (Community Hospitals, Federal Government Hospitals, Non-federal Psychiatric Hospitals, Non-federal Long-term Care Hospitals, Institutional Hospitals [includes prison hospitals, college infirmaries, etc.], Total U.S. Registered Hospitals)
  • Figure 2-10: Number of Hospitals in the U.S., 1975-2015
  • Table 2-17: Statistics for U.S. Hospitals, 2012-2015 (Total Staffed Beds, Total Admissions, Total Expenses)
  • Figure 2-11: U.S. Hospital Length of Stay, Average by Age Group, 2014
  • Growth in Hospital Clinical Laboratories
  • Figure 2-12: Growth in U.S. Hospital Laboratory Locations, mid-2011 through January 2017
  • Physician-office Laboratories
  • Figure 2-13: Number of Physician Offices, United States, 2000-2010, Estimated 2015
  • Growth in Clinical Laboratories in the Physician Office
  • Figure 2-14: Growth in U.S. Physician Office Laboratory Locations, mid-2011 through January 2017
  • Nursing Facility and Home Health
  • Figure 2-15: Number of Nursing Homes (United States), 2000-2014
  • Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
  • Figure 2-16: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, mid-2011 through January 2017
  • Pharmacy-based Laboratories
  • Growth in Pharmacy-Based Clinical Laboratories
  • Figure 2-17: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through January 2017
  • Dialysis Clinics
  • Growth in U.S. Dialysis Clinics and Affiliated Laboratories
  • Figure 2-18: U.S. Dialysis Facilities (Number of Clinics), 1991-2014
  • Figure 2-19: U.S. Dialysis Patients at Year's End, 2009-2014
  • Figure 2-20: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through January 2017

NUMBER OF LABORATORY HEALTH WORKERS BY COUNTRY

  • Figure 2-21: Laboratory Health Workers by Country, 2010-2014 Average (United States, China, Brazil, Korea, Mexico, Canada)

CHAPTER THREE: ISSUES AND TRENDS IN THE CLINICAL LABORATORY INDUSTRY

ISSUES AND TRENDS OVERVIEW

DEMOGRAPHICS

  • Global Demographics
  • Table 3-1: The Global Population, 1980-2050
  • Figure 3-1: The Global Population, 1980-2050 (in millions)
  • Regional Population Overview
  • Table 3-2: World Population by Major Geographic Region, 2010 - 2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of World, World)
  • Figure 3-2: World Population by Major Geographic Region, 2010-2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of World)
  • Aging Populations
  • Table 3-3: Global Population Trends Age 65+, 2000-2050
  • Figure 3-3: Global Population Trends Age 65+, 2000-2050 (Millions)

INCIDENCE OF CHRONIC DISEASES AND CONDITIONS

  • Figure 3-4: Global Causes of Death, 2014 and 2015

SURGICAL PROCEDURE VOLUMES

  • Table 3-4: Global Surgical Procedure Volume Forecast by Region, 2015-2030*
  • (procedures in thousands) (Northern America, Europe, Asia Pacific, Latin America, Rest of World, Total) .. 69

REGULATORY OVERVIEW

  • Certificate of Waiver
  • Table 3-5: Selected CLIA Waived Laboratory Tests
  • Certificate of Provider-Performed Microscopy Procedures (PPMP)
  • Table 3-6: Provider-Performed Microscopy Procedures
  • Certificate of Compliance and Certificate of Accreditation
  • Figure 3-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), January 2017
  • Table 3-7: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), January 2017
  • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
  • Table 3-8: CLIA Exempt States, Number of Laboratories, January 2017 (New York, Washington)

PAYERS AND REIMBURSEMENT

  • Laboratory Service Payer Types
  • Table 3-9: U.S. Clinical Laboratory Clients and Payers by Type (%) (Medicare and Medicaid, Private Patient, Commercial Insurance, Managed Care)
  • Figure 3-6: Clinical Laboratory Clients and Payers by Type (Medicare/Medicaid, Private, Commercial, Managed Care)
  • Trends in Medicare Reimbursement
  • Table 3-10: Medicare Reimbursement Trends, 2009 vs. 2013 vs. 2015 vs. 2016
  • Health Care Reform
  • Protecting Access to Medicare Act (PAMA) of 2014
  • Bundled Insurance Payments for ESRD Patients
  • Table 3-11: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2017)
  • Table 3-12: Comparison between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)
  • Commercial Insurance Providers

NEW DEVELOPMENTS IN INFORMATION TECHNOLOGY

CHAPTER FOUR: LEADING MARKET PARTICIPANTS

SUMMARY

  • Figure 4-1: Leading Market Participants, Global Service Revenues, 2014, 2015 and 2016 ($millions)
  • U.S. COMPETITIVE ANALYSIS
  • Table 4-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
  • Figure 4-2: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
  • Figure 4-3: Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers, 2010 vs. 2016

ALERE, INC.

  • Company Overview
  • Table 4-2: Alere Corporate Details
  • Performance Review
  • Figure 4-4: Alere Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

BIO-REFERENCE LABORATORIES - OPKO

  • Company Overview
  • Table 4-3: Bio-Reference Laboratories Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

DAVITA HEALTHCARE PARTNERS, INC.

  • Company Overview
  • Table 4-4: DaVita Healthcare Corporate Details
  • Performance Review
  • Figure 4-5: DaVita Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

GENOMIC HEALTH, INC.

  • Company Overview
  • Table 4-5: Genomic Health Corporate Details
  • Performance Review
  • Figure 4-6: Genomic Health Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

LABORATORY CORPORATION OF AMERICA

  • Company Overview
  • Table 4-6: Laboratory Corporation of America Corporate Details
  • Performance Review
  • Figure 4-7: Laboratory Corporation of America Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

MYRIAD GENETICS, INC.

  • Company Overview
  • Table 4-7: Myriad Genetics Corporate Details
  • Performance Review
  • Figure 4-8: Myriad Genetics Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

NEOGENOMICS, INC.

  • Company Overview
  • Table 4-8: NeoGenomics, Inc. Corporate Details
  • Performance Review
  • Figure 4-9: NeoGenomics Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

QUEST DIAGNOSTICS, INC.

  • Company Overview
  • Table 4-9: Quest Diagnostics Corporate Details
  • Performance Review
  • Figure 4-10: Quest Diagnostics Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SIEMENS HEALTHINEERS

  • Company Overview
  • Table 4-10: Siemens Healthineers Corporate Details
  • Performance Review
  • Figure 4-11: Siemens' Healthineers Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SONIC HEALTHCARE LIMITED

  • Company Overview
  • Table 4-11: Sonic Healthcare Corporate Details
  • Performance Review
  • Figure 4-12: Sonic Healthcare Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SPECTRA LABORATORIES: A FRESENIUS COMPANY

  • Company Overview
  • Table 4-12: Spectra Laboratories Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SYNLAB INTERNATIONAL GMBH

  • Company Overview
  • Table 4-13: SYNLAB International Corporate Details
  • Performance Review
  • Table 4-14: SYNLAB International Business Combination Details
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

CHAPTER FIVE: MARKET TRENDS AND SUMMARY

GLOBAL MARKET OVERVIEW

  • Table 5-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer's level)
  • Figure 5-1: Global Clinical Laboratory Market Analysis: 2010-2021

SERVICE MARKETS BY TEST SEGMENT

  • Figure 5-2: Global Clinical Laboratory Revenue Share by General Test Segment, 2016 (%)
  • Table 5-2: Global Clinical Laboratory Market Analysis by Test Segment (Routine vs. Specialty), 2010-2021 (in millions of dollars at the manufacturers' level)
  • Routine Testing
  • Table 5-3: Most Common Performed Routine Tests by Order Request, 2016
  • Figure 5-3: Global Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2010-2021
  • Specialty Testing
  • Table 5-4: Most Common Performed Specialty Tests by Order Request, 2016
  • Figure 5-4: Global Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2010-2021

CHAPTER SIX: REGIONAL MARKETS AND TRENDS

OVERVIEW

  • Table 6-1: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
  • Figure 6-1: Global Clinical Laboratory Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America)

NORTHERN AMERICAN MARKET OVERVIEW

  • Table 6-2: Northern America Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (Canada, United States, Rest of Northern America)
  • U.S. Clinical Laboratory Market
  • Table 6-3: U.S. Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer's level)
  • Figure 6-2: U.S. Clinical Laboratory Market Analysis: 2010-2021
  • Market Analysis by Laboratory Type
  • Table 6-4: U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (in millions of dollars at the manufacturers' level) (Hospital-based, Physician-office, Independent, Total)
  • Figure 6-3: U.S. Clinical Laboratory Market Share by Laboratory Type, 2016 (Independent, Hospital-based, Physician-office)
  • Figure 6-4: U.S. Clinical Laboratory Market Share by Laboratory Type, 2021 (Independent, Hospital-based, Physician-office)
  • Market Analysis by Test Type
  • Figure 6-5: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2016 (Routine Clinical Chemistry, Toxicology / Drug abuse, Tissue Pathology, Other Specialty)

EUROPE AND MIDDLE EAST MARKET OVERVIEW

  • Table 6-5: Europe/Middle East and Africa Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)

ASIA PACIFIC MARKET OVERVIEW

  • Table 6-6: Asia Pacific Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (China, Japan, India, South Korea, Australia, Rest of Asia Pacific, Total)

LATIN AMERICA MARKET OVERVIEW

  • Table 6-7: Latin America Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (Brazil, Mexico, Rest of Latin America, Total)

APPENDIX: LIST OF MAJOR COMPANIES

Back to Top